MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1

BACKGROUND: Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to more advanced stages. The aim here was to investigate stage T1 tumors regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Hans, Hultman, Per, Rosell, Johan, Söderkvist, Peter, Jahnson, Staffan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574032/
https://www.ncbi.nlm.nih.gov/pubmed/23356517
http://dx.doi.org/10.1186/1471-2490-13-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574032/
https://www.ncbi.nlm.nih.gov/pubmed/23356517
http://dx.doi.org/10.1186/1471-2490-13-5

Ejemplares similares